Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Randal J. Kirk currently holds 81,781,816 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randal J. Kirk has been a net buyer of HALO stock. They have purchased $545.9M and sold $141.5M worth of shares.
Randal J. Kirk's most recent insider trade was on Mar 13, 2026, when they sold 143,678 shares at $0.00 per share.
Randal J. Kirk serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 902 insider transactions totaling $687.4M over their tenure at the company.
Randal J. Kirk holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Randal J. Kirk has shown a buying trading pattern, with $545.9M in total purchases and $141.5M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Randal J. Kirk was on Aug 9, 2024, when they purchased $20.0M worth of PGEN shares. This transaction involved 23,529,411 shares at $0.85 per share.
Randal J. Kirk currently owns 81,781,816 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Randal J. Kirk's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Randal J. Kirk has 902 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for Randal J. Kirk and 40,000+ other insiders.